03/20/2019
Postpartum depression is a real disorder, not just symptoms of overwhelm due to lack of sleep and caring for a new baby. According the the CDC, postpartum depression may affect as many as one in nine women.
Here’s why PPD is different than regular depression: the hormone progesterone increases throughout a woman’s pregnancy and then drastically decreases right after she gives birth. Scientists feel that this could be a major cause of postpartum depression.
Postpartum depression can be severely debilitating and can include sleep disruption, lack of appetite, feelings of sadness and apathy for ones health as well as the health of the baby.
Of course, then there’s the mom guilt that mothers feel when they are unable to enjoy what should be a happy time and a time for baby bonding.
According to this article, this new drug, Brexanolone may be a good intervention to treat postpartum depression because it contains a synthetic form of the hormone allopregnanolone, which is a progesterone derivative. In double-blind, placebo-controlled clinical trials, many women with moderate to severe postpartum depression saw a significant improvement of their symptoms within just 24 hours of receiving the drug. The results lasted 30 days after the infusion, which was the length of the trial.
Check out the article below and speak to your physician or women’s health care practitioner if you are concerned about postpartum depression.
The treatment is delivered through a one-time, 60-hour intravenous infusion that may improve symptoms within 24 hours.